Potential mechanisms of muscle mitochondrial dysfunction in aging and obesity and cellular consequences

International Journal of Molecular Sciences

Volumn 10, Issue 1, 2009, Pages 306-324

  Chanséaume, Emilie ^a   Morio, Beatrice ^a  

^a INRA and University of Auvergne   (France)

Author keywords

Insulin resistance; Metabolic disorders; Mitochondrial dysfunction; Obesity; Skeletal muscle; Type 2 diabetes

Indexed keywords

OXIDOREDUCTASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRANSCRIPTION FACTOR;

AGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NONHUMAN; NUTRITIONAL VALUE; OBESITY; OXIDATIVE STRESS; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

INSULIN RESISTANCE; METABOLIC DISORDERS; MITOCHONDRIAL DYSFUNCTION; OBESITY; SKELETAL MUSCLE; TYPE 2 DIABETES;

AGING; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; MITOCHONDRIA, MUSCLE; OBESITY; OXIDATIVE PHOSPHORYLATION;

EID: 59649090730     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10010306     Document Type: Review

References (109)

1. Fredenrich, A.; Grimaldi, P.A. Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7, 377-381.
2. Grimaldi, P.A. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment? Biochimie 2005a, 87, 5-8.
3. Grimaldi, P.A. Roles of PPARdelta in skeletal muscle physiology. Med. Sci. (Paris) 2005b, 21, 239-240.
4. Kliewer, S.A.; Sundseth, S.S.; Jones, S.A.; Brown, P.J.; Wisely, G.B.; Koble, C.S.; Devchand, P.; Wahli, W.; Willson, T.M.; Lenhard, J.M.; Lehmann, J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 1997, 94, 4318-4323.
5. Lapsys, N.M.; Kriketos, A.D.; Lim-Fraser, M.; Poynten, A.M.; Lowy, A.; Furler, S.M.; Chisholm, D.J.; Cooney, G.J. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J. Clin. Endocrinol. Metab. 2000, 85, 4293-4297.
6. Lazennec, G.; Canaple, L.; Saugy, D.; Wahli, W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 2000, 14, 1962-1975.
7. Patti, M.E.; Butte, A.J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R.; Landaker, E.J.; Goldfine, A.B.; Mun, E.; DeFronzo, R.; Finlayson, J.; Kahn, C.R.; Mandarino, L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100, 8466-8471.
8. Sparks, L.M.; Xie, H.; Koza, R.A.; Mynatt, R.; Hulver, M.W.; Bray, G.A.; Smith, S.R. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005, 54, 1926-1933.
9. Tanaka, T.; Yamamoto, J.; Iwasaki, S.; Asaba, H.; Hamura, H.; Ikeda, Y.; Watanabe, M.; Magoori, K.; Ioka, R.X.; Tachibana, K.; Watanabe, Y.; Uchiyama, Y.; Sumi, K.; Iguchi, H.; Ito, S.; Doi, T.; Hamakubo, T.; Naito, M.; Auwerx, J.; Yanagisawa, M.; Kodama, T.; Sakai, J. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 2003, 100, 15924-15929.
10. Zaid, A.; Li, R.; Luciakova, K.; Barath, P.; Nery, S.; Nelson, B.D. On the role of the general transcription factor Sp1 in the activation and repression of diverse mammalian oxidative phosphorylation genes. J. Bioenerg. Biomembr. 1999, 31, 129-135.
11. Yang, X.; Su, K.; Roos, M.D.; Chang, Q.; Paterson, A.J.; Kudlow, J.E. O-linkage of N- acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 2001, 98, 6611-661.
12. Moyes, C.D. Controlling muscle mitochondrial content. J. Exp. Biol. 2003, 206, 4385-4391.
13. Lin, J.; Wu, H.; Tarr, P.T.; Zhang, C.Y.; Wu, Z.; Boss, O.; Michael, L.F.; Puigserver, P.; Isotani, E.; Olson, E.N.; Lowell, B.B.; Bassel-Duby, R.; Spiegelman, B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002a, 418, 797-801.
14. Puigserver, P.; Spiegelman, B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24, 78-90.
15. Chabi, B.; Adhihetty, P.J.; Ljubicic, V.; Hood, D.A. How is mitochondrial biogenesis affected in mitochondrial disease? Med. Sci. Sports Exerc. 2005, 37, 2102-2110.
16. Hood, D.A.; Irrcher, I.; Ljubicic, V.; Joseph, A.M. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Biol. 2006, 209, 2265-2275.
17. Luquet, S.; Lopez-Soriano, J.; Holst, D.; Fredenrich, A.; Melki, J.; Rassoulzadegan, M.; Grimaldi, P.A. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 2003, 17, 2299-22301.
18. Befroy, D.E.; Falk Petersen, K.; Dufour, S.; Mason, G.F.; de Graaf, R.A.; Rothman, D.L.; Shulman, G.I. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients. Diabetes 2007, 57, 1376-1381.
19. Petersen, K.F.; Dufour, S.; Befroy, D.; Garcia, R.; Shulman, G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350, 664-671.
20. Petersen, K.F.; Dufour, S.; Shulman, G.I. Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents. PLoS Med. 2005, 2, e233.
21. Petersen, K.F.; Shulman, G.I. Etiology of insulin resistance. Am. J. Med. 2006, 119, S10-S16.
22. Drew, B.; Phaneuf, S.; Dirks, A.; Selman, C.; Gredilla, R.; Lezza, A.; Barja, G.; Leeuwenburgh, C. Effects of aging and caloric restriction on mitochondrial energy production in gastrocnemius muscle and heart. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R474-R480.
23. Kwong, L.K.; Sohal, R.S. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch. Biochem. Biophys. 2000, 373, 16-22.
24. Barrientos, A.; Casademont, J.; Rotig, A.; Miro, O.; Urbano-Marquez, A.; Rustin, P.; Cardellach, F. Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem. Biophys. Res. Commun. 1996, 229, 536-539.
25. Brierley, E.J.; Johnson, M.A.; James, O.F.; Turnbull, D.M. Effects of physical activity and age on mitochondrial function. QJM 1996, 89, 251-258.
26. Conley, K.E.; Jubrias, S.A.; Esselman, P.C. Oxidative capacity and ageing in human muscle. J. Physiol. 2000, 526, 203-210.
27. Petersen, K.F.; Befroy, D.; Dufour, S.; Dziura, J.; Ariyan, C.; Rothman, D.L.; DiPietro, L.; Cline, G.W.; Shulman, G.I. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003, 300, 1140-1142.
28. Rasmussen, U.F.; Krustrup, P.; Kjaer, M.; Rasmussen, H.N. Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch. 2003, 446, 270-278.
29. Rimbert, V.; Boirie, Y.; Bedu, M.; Hocquette, J.F.; Ritz, P.; Morio, B. Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J. 2004, 18, 737-739.
30. Kelley, D.; He, J.; Menshikova, E.; Ritov, V. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51, 2944-2950.
31. Simoneau, J.A.; Kelley, D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 1997, 83, 166-171.
32. Petersen, K.F.; Dufour, S.; Shulman, G.I. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of Type 2 Diabetic Parents. PLoS Med. 2005a, 2, e233.
33. Hojlund, K.; Wrzesinski, K.; Larsen, P.M.; Fey, S.J.; Roepstorff, P.; Handberg, A.; Dela, F.; Vinten, J.; McCormack, J.G.; Reynet, C.; Beck-Nielsen, H. Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J. Biol. Chem. 2003, 278, 10436-10442.
34. Liang, P.; Hughes, V.; Fukagawa, N.K. Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes 1997, 46, 920-923.
35. Guillet, C.; Prod'homme, M.; Balage, M.; Gachon, P.; Giraudet, C.; Morin, L.; Grizard, J.; Boirie, Y. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. Faseb J. 2004, 18, 1586-7.
36. Rooyackers, O.E.; Adey, D.B.; Ades, P.A.; Nair, K.S. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA 1996a, 93, 15364-15369.
37. Balagopal, P.; Rooyackers, O.E.; Adey, D.B.; Ades, P.A.; Nair, K.S. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am. J. Physiol. 1997, 273, E790-E800.
38. Boirie, Y.; Short, K.R.; Ahlman, B.; Charlton, M.; Nair, K.S. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 2001, 50, 2652-2658.
39. Rooyackers, O.E.; Adey, D.B.; Ades, P.A.; Nair, K.S. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc. Natl. Acad. Sci. USA 1996, 93, 15364-15369.
40. Halvatsiotis, P.; Short, K.R.; Bigelow, M.; Nair, K.S. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002, 51, 2395-2404.
41. Stump, C.S.; Short, K.R.; Bigelow, M.L.; Schimke, J.M.; Nair, K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. USA 2003, 100, 7996-8001.
42. Boirie, Y. Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Trends Endocrinol. Metab. 2003, 14, 393-394.
43. Southgate, R.J.; Bruce, C.R.; Carey, A.L.; Steinberg, G.R.; Walder, K.; Monks, R.; Watt, M.J.; Hawley, J.A.; Birnbaum, M.J.; Febbraio, M.A. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. Faseb J. 2005, 19, 2072-2074.
44. Short, K.R.; Vittone, J.L.; Bigelow, M.L.; Proctor, D.N.; Rizza, R.A.; Coenen-Schimke, J.M.; Nair, K.S. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003, 52, 1888-1896.
45. Chanseaume, E.; Malpuech-Brugere, C.; Patrac, V.; Bielicki, G.; Rousset, P.; Couturier, K.; Salles, J.; Renou, J.P.; Boirie, Y.; Morio, B. Diets high in sugar, fat, and energy induce muscle type-specific adaptations in mitochondrial functions in rats. J. Nutr. 2006, 136, 2194-2200.
46. Iossa, S.; Lionetti, L.; Mollica, M.P.; Crescenzo, R.; Botta, M.; Barletta, A.; Liverini, G. Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br. J. Nutr. 2003, 90, 953-960.
47. Obici, S.; Wang, J.; Chowdury, R.; Feng, Z.; Siddhanta, U.; Morgan, K.; Rossetti, L. Identification of a biochemical link between energy intake and energy expenditure. J. Clin. Invest. 2002, 109, 1599-1605.
48. Mootha, V.K.; Lindgren, C.M.; Eriksson, K.F.; Subramanian, A.; Sihag, S.; Lehar, J.; Puigserver, P.; Carlsson, E.; Ridderstrale, M.; Laurila, E.; Houstis, N.; Daly, M.J.; Patterson, N.; Mesirov, J.P.; Golub, T.R.; Tamayo, P.; Spiegelman, B.; Lander, E.S.; Hirschhorn, J.N.; Altshuler, D.; Groop, L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34, 267-273.
49. Chavez, J.A.; Holland, W.L.; Bar, J.; Sandhoff, K.; Summers, S.A. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J. Biol. Chem. 2005, 280, 20148-20153.
50. Shulman, G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106, 171-176.
51. Staiger, H.; Staiger, K.; Haas, C.; Weisser, M.; Machicao, F.; Haring, H.U. Fatty acid-induced differential regulation of the genes encoding peroxisome proliferator -activated receptor-gamma coactivator-1alpha and -1beta in human skeletal muscle cells that have been differentiated in vitro. Diabetologia 2005, 48, 2115-2118.
52. Simoneau, J.A.; Veerkamp, J.H.; Turcotte, L.P.; Kelley, D.E. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. Faseb J. 1999, 13, 2051-2060.
53. Coll, T.; Jove, M.; Rodriguez-Calvo, R.; Eyre, E.; Palomer, X.; Sanchez, R.M.; Merlos, M.; Laguna, J.C. Vazquez-Carrera, M. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006, 55, 2779-2787.
54. Crunkhorn, S.; Dearie, F.; Mantzoros, C.; Gami, H.; da Silva, W.S.; Espinoza, D.; Faucette, R.; Barry, K.; Bianco, A.C.; Patti, M.E. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: Potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 2007, 282, 15439-15450.
55. Benton, C.R.; Han, X.X.; Febbraio, M.; Graham, T.E.; Bonen, A. Inverse relationship between PGC-1alpha protein expression and triacylglycerol accumulation in rodent skeletal muscle. J. Appl. Physiol. 2006, 100, 377-383.
56. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109-1122.
57. Richardson, D.K.; Kashyap, S.; Bajaj, M.; Cusi, K.; Mandarino, S.J.; Finlayson, J.; DeFronzo, R.A.; Jenkinson, C.P.; Mandarino, L.J. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J. Biol. Chem. 2005, 280, 10290-10297.
58. Brindley, D.N.; Wang, C.N.; Mei, J.; Xu, J.; Hanna, A.N. Tumor necrosis factor-alpha and ceramides in insulin resistance. Lipids 1999, 34 Suppl., S85-S88.
59. Kern, P.A.; Di Gregorio, G.B.; Lu, T.; Rassouli, N.; Ranganathan, G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52, 1779-1785.
60. Saghizadeh, M.; Ong, J.M.; Garvey, W.T.; Henry, R.R.; Kern, P.A. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J. Clin. Invest. 1996, 97, 1111-1116.
61. Neels, J.G.; Pandey, M.; Hotamisligil, G.S.; Samad, F. Autoamplification of tumor necrosis factor-alpha: A potential mechanism for the maintenance of elevated tumor necrosis factor-alpha in male but not female obese mice. Am. J. Pathol. 2006, 168, 435-444.
62. Halse, R.; Pearson, S.L.; McCormack, J.G.; Yeaman, S.J.; Taylor, R. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 2001, 50, 1102-1109.
63. Rieusset, J.; Bouzakri, K.; Chevillotte, E.; Ricard, N.; Jacquet, D.; Bastard, J.P.; Laville, M.; Vidal, H. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 2004, 53, 2232-2241.
64. Jove, M.; Planavila, A.; Sanchez, R.M.; Merlos, M.; Laguna, J.C.; Vazquez-Carrera, M. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 2006, 147, 552-561.
65. Steinberg, G.R.; Michell, B.J.; van Denderen, B.J.; Watt, M.J.; Carey, A.L.; Fam, B.C.; Andrikopoulos, S.; Proietto, J.; Gorgun, C.Z.; Carling, D.; Hotamisligil, G.S.; Febbraio, M.A.; Kay, T.W.; Kemp, B.E. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 2006, 4, 465-474.
66. Munoz-Fernandez, M.A.; Fresno, M. The role of tumour necrosis factor, interleukin 6, interferon- gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 1998, 56, 307-340.
67. Valerio, A.; Cardile, A.; Cozzi, V.; Bracale, R.; Tedesco, L.; Pisconti, A.; Palomba, L.; Cantoni, O.; Clementi, E.; Moncada, S.; Carruba, M.O.; Nisoli, E. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. 2006, 116, 2791-2798.
68. Perreault, M.; Dombrowski, L.; Marette, A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia 2000, 43, 427-437.
69. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357, 593-615.
70. Nisoli, E.; Clementi, E.; Paolucci, C.; Cozzi, V.; Tonello, C.; Sciorati, C.; Bracale, R.; Valerio, A.; Francolini, M.; Moncada, S.; Carruba, M.O. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299, 896-899.
71. Nisoli, E.; Falcone, S.; Tonello, C.; Cozzi, V.; Palomba, L.; Fiorani, M.; Pisconti, A.; Brunelli, S.; Cardile, A.; Francolini, M.; Cantoni, O.; Carruba, M.O.; Moncada, S.; Clementi, E. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA 2004, 101, 16507-16512.
72. Hickner, R.C.; Kemeny, G.; Stallings, H.W.; Manning, S.M.; McIver, K.L. Relationship between body composition and skeletal muscle eNOS. Int. J. Obes. (Lond) 2006, 30, 308-312.
73. Almendro, V.; Busquets, S.; Ametller, E.; Carbo, N.; Figueras, M.; Fuster, G.; Argiles, J.M.; Lopez-Soriano, F.J. Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]- triolein load. Biochim. Biophys. Acta 2006, 1761, 37-42.
74. Busquets, S.; Figueras, M.; Almendro, V.; Lopez-Soriano, F.J.; Argiles, J.M. Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim. Biophys. Acta 2006, 1760, 1613-1617.
75. Zong, H.; Ren, J.M.; Young, L.H.; Pypaert, M.; Mu, J.; Birnbaum, M.J.; Shulman, G.I. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 2002, 99, 15983-15987.
76. Turko, I.V.; Li, L.; Aulak, K.S.; Stuehr, D.J.; Chang, J.Y.; Murad, F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J. Biol. Chem. 2003, 278, 33972-33977.
77. Brownlee, M. A radical explanation for glucose-induced beta cell dysfunction. J. Clin. Invest. 2003, 112, 1788-1790.
78. Lowell, B.B.; Shulman, G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307, 384-387.
79. Bonnard, C.; Durand, A.; Peyrol, S.; Chanseaume, E.; Chauvin, M.A.; Morio, B.; Vidal, H.; Rieusset, J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced nsulin-resistant mice. J. Clin. Invest. 2008, 118, 789-800.
80. Nishikawa, T.; Edelstein, D.; Du, X.L.; Yamagishi, S.; Matsumura, T.; Kaneda, Y.; Yorek, M.A.; Beebe, D.; Oates, P.J.; Hammes, H.P.; Giardino, I.; Brownlee, M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404, 787-790.
81. Zachara, N.E.; Hart, G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta 2004, 1673, 13-28.
82. Bassett, D.R., Jr.; Howley, E.T. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med. Sci. Sports Exerc. 2000, 32, 70-84.
83. Haseler, L.J.; Lin, A.P.; Richardson, R.S. Skeletal muscle oxidative metabolism in sedentary humans: 31P-MRS assessment of O2 supply and demand limitations. J. Appl. Physiol. 2004, 97, 1077-1081.
84. Arenas, J.; Martin, M.A. Metabolic intolerance to exercise. Neurologia 2003, 18, 291-302.
85. Coggan, A.R.; Abduljalil, A.M.; Swanson, S.C.; Earle, M.S.; Farris, J.W.; Mendenhall, L.A.; Robitaille, P.M. Muscle metabolism during exercise in young and older untrained and endurance- trained men. J. Appl. Physiol. 1993, 75, 2125-2133.
86. Mousson, B.; Collombet, J.M.; Dumoulin, R.; Carrier, H.; Flocard, F.; Bouzidi, M.; Godinot, C.; Maire, I.; Mathieu, M.; Quard, S. An abnormal exercise test response revealing a respiratory chain complex III deficiency. Acta Neurol. Scand. 1995, 91, 488-493.
87. Haller, R.G.; Lewis, S.F.; Estabrook, R.W.; DiMauro, S.; Servidei, S.; Foster, D.W. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J. Clin. Invest. 1989, 84, 155-161.
88. Russell, A.P.; Gastaldi, G.; Bobbioni-Harsch, E.; Arboit, P.; Gobelet, C.; Deriaz, O.; Golay, A.; Witztum, J.L.; Giacobino, J.P. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett. 2003, 551, 104-106.
89. Nakagawa, Y. Initiation of apoptotic signal by the peroxidation of cardiolipin of mitochondria. Ann. NY Acad. Sci. 2004, 1011, 177-184.
90. Bulteau, A.L.; Szweda, L.I.; Friguet, B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp. Gerontol. 2006, 41, 653-657.
91. Fridlyand, L.E.; Philipson, L.H. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 2006, 8, 136-145.
92. Jezek, P.; Hlavata, L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 2005, 37, 2478-2503.
93. Lenaz, G.; D'Aurelio, M.; Merlo Pich, M.; Genova, M.L.; Ventura, B.; Bovina, C.; Formiggini, G.; Parenti Castelli, G. Mitochondrial bioenergetics in aging. Biochim. Biophys. Acta 2000, 1459, 397-404.
94. Kayali, R.; Cakatay, U.; Telci, A.; Akcay, T.; Sivas, A.; Altug, T. Decrease in mitochondrial oxidative protein damage parameters in the streptozotocin-diabetic rat. Diabetes Metab. Res. Rev. 2004, 20, 315-321.
95. Kelley, D.E.; Mandarino, L.J. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes 2000, 49, 677-683.
96. Storlien, L.; Oakes, N.D.; Kelley, D.E. Metabolic flexibility. Proc. Nutr. Soc. 2004, 63, 363-368.
97. Kraegen, E.W.; Cooney, G.J.; Turner, N. Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction. Proc. Natl Acad. Sci. USA 2008, 105, 7627-7628.
98. Holloszy, J.O. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am. J. Clin. Nutr. 2008, December 3.
99. Bonen, A.; Parolin, M.L.; Steinberg, G.R.; Calles-Escandon, J.; Tandon, N.N.; Glatz, J.F.; Luiken, J.J.; Heigenhauser, G.J.; Dyck, D.J. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. Faseb J. 2004, 18, 1144-1146.
100. He, J.; Watkins, S.; Kelley, D. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001, 50, 817-823.
101. Schrauwen, P.; Hesselink, M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53, 1412-1417.
102. Bruce, C.R.; Anderson, M.J.; Carey, A.L.; Newman, D.G.; Bonen, A.; Kriketos, A.D.; Cooney, G.J.; Hawley, J.A. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 2003, 88, 5444-5451.
103. Morino, K.; Petersen, K.F.; Dufour, S.; Befroy, D.; Frattini, J.; Shatzkes, N.; Neschen, S.; White, M.F.; Bilz, S.; Sono, S.; Pypaert, M.; Shulman, G.I. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 2005, 115, 3587-3593.
104. Ritov, V.B.; Menshikova, E.V.; He, J.; Ferrell, R.E.; Goodpaster, B.H.; Kelley, D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54, 8-14.
105. Petersen, K.F.; Shulman, G.I. Cellular mechanism of insulin resistance in skeletal muscle. J. R. Soc. Med. 2002, 95 Suppl 42, 8-13.
106. Forouhi, N.G.; Jenkinson, G.; Thomas, E.L.; Mullick, S.; Mierisova, S.; Bhonsle, U.; McKeigue, P.M.; Bell, J.D. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 1999, 42, 932-935.
107. Krssak, M.; Falk Petersen, K.; Dresner, A.; DiPietro, L.; Vogel, S.M.; Rothman, D.L.; Roden, M.; Shulman, G.I. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 1999, 42, 113-116.
108. Perseghin, G.; Scifo, P.; De Cobelli, F.; Pagliato, E.; Battezzati, A.; Arcelloni, C.; Vanzulli, A.; Testolin, G.; Pozza, G.; Del Maschio, A.; Luzi, L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999, 48, 1600-1606.
109. Chanseaume, E.; Tardy, A.L.; Salles, J.; Giraudet, C.; Rousset, P.; Tissandier, A.; Boirie, Y.; Morio, B. Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. Obesity (Silver Spring) 2007, 15, 50-59.